Abstract:INTRODUCTION: Immune checkpoint inhibitors (ICI) in metastatic melanoma results in durable responses in ∼50% of patients. Our understanding of the tumour immune microenvironment (TME) features underpinning ICI response or resistance is currently incomplete. METHODS: To address this issue, we explored the TME of melanoma lymph node metastases (MLN mets) at a spatial (n = 32) and a single cell level (n=24). MLN mets were either from ICI-responder and ICI-resistant patients or untreated controls. We used multiplex IHC and our SPIAT algorithm to examine the spatial immune context of the TME, and also analyzed gene expression by RNAseq. Cells were also isolated from fresh tissue before or after ICI and analyzed by single cell RNAseq and TCRseq to derive high dimension data on T cells and their clonality, all other immune and melanoma cells. Finally, we performed cell-cell interactome and neighborhood analyses to reveal which cell and molecular interactions were associated with response. RESULTS: In patients who responded to ICI, both CD4+ and CD8+ tissue resident memory (TRM) T cell subset density were significantly increased within the tumor, and this correlated with closer distance to melanoma cells. (p<0.05). Single cell data revealed multiple clusters of immune cells (T, B, NK, Mø, DC) and melanoma cells. CD8+ T cell clustering revealed heterogeneous differentiation states. In ICI responders, we observed enrichment for TRM with an earlier transcriptional profile (TCF1+ Tpex.TRM and early TEM.TRM) and lower expression of the exhausted T cell (Texh) gene signature (p<0.05). Hyperexpanded CD8+ T cell clones were present in the TRM cell cluster and were enriched in the responder patients but not in those with resistant disease. CD4+ T cells showed both TRM and TFH clusters with shared expression of multiple genes, with CD4+ TRM also expressed a cytotoxicity gene module. Additionally, Mø and melanoma cells in resistant disease had significantly higher IFNg and IFN-I response gene expression levels compared to tumors from responders (p<0.05), suggesting that chronic activation of T cells in LN mets could lead to the observed Texh phenotype. Interactome analysis displayed putative interactions between CD4+ and CD8+ TRM via the CCL4-CCR5 axis in the ICI responders. This was confirmed by spatial analysis of neighborhood archetypes, which showed significantly increased cell-cell contact between both TRM subsets within the tumor of responders (p<0.05). Finally, conventional dendritic cells interact with both CD8+ and CD4+ TRM subsets in the tumor of responders, providing key signals for maintenance of the TRM pool within the tumor. CONCLUSIONS: MLN mets that respond to ICI are characterized by increased TRM comprising hyperexpanded TCR clones and complex TRM-containing neighborhood archetypes. Whilst these tumors show increased global inflammation, at a single cell level the resistant tumors have increased Texh and greater expression of IFN-regulated genes in melanoma cells and macrophages suggesting ineffective response to chronic antigen stimulation. Citation Format: Andrea Di Pietro, Lewis Au, Patrick Crock, Niko Thio, Angela Pizzolla, Marina Bacac, Ramona Schlenker, Aparna Rao, L Spain, David Gyorki, Shahneen Sandhu, Grant McArthur, Paul J Neeson. Tissue resident memory (TRM) T cells and dendritic cells form an in situ archetype for improved response to immune checkpoint therapy in metastatic melanoma [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Tumor Immunology and Immunotherapy; 2024 Oct 18-21; Boston, MA. Philadelphia (PA): AACR; Cancer Immunol Res 2024;12(10 Suppl) nr A006.

T cell interaction with activated endothelial cells primes for tissue-residency

Tissue–Resident Memory T Cells in Chronic Inflammation—Local Cells with Systemic Effects?

CD8+ Resident Memory T Cells and Viral Infection

Tissue-resident memory T cells: local specialists in immune defence

Intestinal tissue‐resident memory T cells maintain distinct identity from circulating memory T cells after in vitro restimulation

The role of circulating T cells with a tissue resident phenotype (ex-TRM) in health and disease

Retinoic acid and TGF-β orchestrate organ-specific programs of tissue residency

Characteristics of CD8+ and CD4+ Tissue-Resident Memory Lymphocytes in the Gastrointestinal Tract

The emerging role of effector functions exerted by tissue-resident memory T cells

CD8+ Tissue-Resident Memory T Cells: Versatile Guardians of the Tissue

Tissue-Resident Memory T Cell: Ontogenetic Cellular Mechanism and Clinical Translation

Resident Memory T Cells in the Atherosclerotic Lesion Associate With Reduced Macrophage Content and Increased Lesion Stability

Developmental plasticity allows outside-in immune responses by resident memory T cells

Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy

Resident memory (TRM) cells sustain immunity to cancer at sites of frequent metastasis

Tissue resident memory CD4+ T cells are sustained by site-specific levels of self-renewal and replacement from precursors

Tissue-Resident Memory T Cells in Allergy

Tissue-resident memory T cells in tumor immunity and immunotherapy

The integrated stress response/eIF2a pathway controls cytokine production in tissue-resident memory CD4 T cells

Tissue-Specific Control of Tissue-Resident Memory T Cells.

Abstract A006: Tissue resident memory (TRM) T cells and dendritic cells form an in situ archetype for improved response to immune checkpoint therapy in metastatic melanoma